Nls Pharmaceutics Ag Stock Price History
| NLSPW Stock | USD 0.02 0.0001 0.67% |
If you're considering investing in NLS Stock, it is important to understand the factors that can impact its price. As of today, the current price of NLS Pharmaceutics stands at 0.02, as last reported on the 5th of August, with the highest price reaching 0.02 and the lowest price hitting 0.02 during the day. NLS Pharmaceutics is out of control given 3 months investment horizon. NLS Pharmaceutics has Sharpe Ratio of 0.13, which conveys that the firm had a 0.13 % return per unit of standard deviation over the last 3 months. We were able to interpolate data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 4.24% are justified by taking the suggested risk. Use NLS Pharmaceutics Risk Adjusted Performance of 0.1111, mean deviation of 17.99, and Market Risk Adjusted Performance of (1.67) to evaluate company specific risk that cannot be diversified away. NLS Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Sharpe Ratio = 0.1264
| Best Portfolio | Best Equity | NLSPW | ||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 33.57 actual daily | 96 96% of assets are less volatile |
Expected Return
| 4.24 actual daily | 85 85% of assets have lower returns |
Risk-Adjusted Return
| 0.13 actual daily | 9 91% of assets perform better |
Based on monthly moving average NLS Pharmaceutics is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of NLS Pharmaceutics by adding it to a well-diversified portfolio.
NLS Pharmaceutics Stock Price History Chart
There are several ways to analyze NLS Stock price data. The simplest method is using a basic NLS candlestick price chart, which shows NLS Pharmaceutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | June 3, 2025 | 0.033 |
| Lowest Price | May 15, 2025 | 0.004 |
NLS Pharmaceutics August 5, 2025 Stock Price Synopsis
Various analyses of NLS Pharmaceutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell NLS Stock. It can be used to describe the percentage change in the price of NLS Pharmaceutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of NLS Stock.| NLS Pharmaceutics Price Daily Balance Of Power | 0.11 | |
| NLS Pharmaceutics Accumulation Distribution | 149.06 | |
| NLS Pharmaceutics Price Rate Of Daily Change | 1.01 |
NLS Pharmaceutics August 5, 2025 Stock Price Analysis
NLS Stock Price History Data
The price series of NLS Pharmaceutics for the period between Wed, May 7, 2025 and Tue, Aug 5, 2025 has a statistical range of 0.03 with a coefficient of variation of 35.51. The daily prices for the period are spread out with arithmetic mean of 0.02. The median price for the last 90 days is 0.02.| Open | High | Low | Close | Volume | ||
08/05/2025 | 0.02 | 0.02 | 0.02 | 0.02 | 2,650 | |
08/04/2025 | 0.02 | 0.02 | 0.01 | 0.01 | 2,835 | |
08/01/2025 | 0.01 | 0.02 | 0.01 | 0.01 | 2,200 | |
07/31/2025 | 0.02 | 0.02 | 0.01 | 0.01 | 25,654 | |
07/30/2025 | 0.02 | 0.02 | 0.02 | 0.02 | 13,762 | |
07/29/2025 | 0.01 | 0.02 | 0.01 | 0.02 | 28,400 | |
07/28/2025 | 0.02 | 0.02 | 0.01 | 0.01 | 3,500 | |
07/25/2025 | 0.01 | 0.02 | 0.01 | 0.01 | 3,700 | |
07/24/2025 | 0.02 | 0.02 | 0.01 | 0.01 | 1,400 | |
07/23/2025 | 0.01 | 0.02 | 0.01 | 0.01 | 53,600 | |
07/22/2025 | 0.01 | 0.02 | 0.01 | 0.01 | 40,600 | |
07/21/2025 | 0.02 | 0.02 | 0.01 | 0.01 | 17,500 | |
07/18/2025 | 0.02 | 0.02 | 0.02 | 0.02 | 1,800 | |
07/17/2025 | 0.01 | 0.02 | 0.01 | 0.01 | 13,300 | |
07/16/2025 | 0.02 | 0.02 | 0.02 | 0.02 | 4,700 | |
07/15/2025 | 0.02 | 0.02 | 0.02 | 0.02 | 3,900 | |
07/14/2025 | 0.02 | 0.02 | 0.02 | 0.02 | 22,800 | |
07/11/2025 | 0.02 | 0.02 | 0.02 | 0.02 | 7,200 | |
07/10/2025 | 0.02 | 0.02 | 0.02 | 0.02 | 5,800 | |
07/09/2025 | 0.02 | 0.02 | 0.02 | 0.02 | 3,800 | |
07/08/2025 | 0.02 | 0.02 | 0.02 | 0.02 | 4,500 | |
07/07/2025 | 0.02 | 0.02 | 0.02 | 0.02 | 13,900 | |
07/03/2025 | 0.02 | 0.02 | 0.02 | 0.02 | 4,100 | |
07/02/2025 | 0.02 | 0.02 | 0.01 | 0.02 | 8,900 | |
07/01/2025 | 0.02 | 0.02 | 0.02 | 0.02 | 5,929 | |
06/30/2025 | 0.02 | 0.02 | 0.02 | 0.02 | 34,361 | |
06/27/2025 | 0.03 | 0.03 | 0.02 | 0.02 | 28,000 | |
06/26/2025 | 0.03 | 0.03 | 0.01 | 0.02 | 18,700 | |
06/25/2025 | 0.01 | 0.03 | 0.01 | 0.03 | 17,800 | |
06/24/2025 | 0.03 | 0.03 | 0.01 | 0.01 | 18,600 | |
06/23/2025 | 0.02 | 0.02 | 0.01 | 0.02 | 9,100 | |
06/20/2025 | 0.01 | 0.02 | 0.01 | 0.01 | 57,600 | |
06/18/2025 | 0.02 | 0.02 | 0.01 | 0.01 | 23,407 | |
06/17/2025 | 0.01 | 0.01 | 0.01 | 0.01 | 46,700 | |
06/16/2025 | 0.02 | 0.02 | 0.01 | 0.01 | 43,000 | |
06/13/2025 | 0.02 | 0.02 | 0.02 | 0.02 | 18,100 | |
06/12/2025 | 0.02 | 0.02 | 0.02 | 0.02 | 38,200 | |
06/11/2025 | 0.02 | 0.02 | 0.02 | 0.02 | 22,500 | |
06/10/2025 | 0.02 | 0.02 | 0.02 | 0.02 | 15,200 | |
06/09/2025 | 0.02 | 0.02 | 0.02 | 0.02 | 594,600 | |
06/06/2025 | 0.02 | 0.03 | 0.02 | 0.02 | 70,100 | |
06/05/2025 | 0.02 | 0.02 | 0.02 | 0.02 | 58,800 | |
06/04/2025 | 0.04 | 0.04 | 0.02 | 0.03 | 33,700 | |
06/03/2025 | 0.02 | 0.04 | 0.02 | 0.03 | 32,500 | |
06/02/2025 | 0.04 | 0.04 | 0.02 | 0.03 | 30,700 | |
05/30/2025 | 0.02 | 0.04 | 0.02 | 0.03 | 94,400 | |
05/29/2025 | 0.02 | 0.03 | 0.02 | 0.02 | 30,700 | |
05/28/2025 | 0.02 | 0.03 | 0.01 | 0.03 | 236,300 | |
05/27/2025 | 0.02 | 0.02 | 0.02 | 0.02 | 41,700 | |
05/23/2025 | 0.01 | 0.02 | 0.01 | 0.01 | 58,779 | |
05/22/2025 | 0.01 | 0.02 | 0.01 | 0.01 | 50,300 | |
05/21/2025 | 0.02 | 0.02 | 0.01 | 0.01 | 300,530 | |
05/20/2025 | 0.01 | 0.02 | 0.01 | 0.02 | 338,800 | |
05/19/2025 | 0.01 | 0.01 | 0.01 | 0.01 | 16,800 | |
05/16/2025 | 0.01 | 0.01 | 0.01 | 0.01 | 4,500 | |
05/15/2025 | 0.01 | 0.01 | 0 | 0 | 21,800 | |
05/14/2025 | 0.01 | 0.01 | 0.01 | 0.01 | 5.00 | |
05/13/2025 | 0.01 | 0.01 | 0 | 0.01 | 57,400 | |
05/12/2025 | 0 | 0.01 | 0 | 0.01 | 43,000 | |
05/09/2025 | 0 | 0.01 | 0 | 0.01 | 5,800 | |
05/08/2025 | 0.01 | 0.01 | 0 | 0.01 | 68,000 |
About NLS Pharmaceutics Stock history
NLS Pharmaceutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for NLS is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in NLS Pharmaceutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing NLS Pharmaceutics stock prices may prove useful in developing a viable investing in NLS Pharmaceutics
NLS Pharmaceutics AG, a biopharmaceutical company, engages in the discovery and development of drug therapies to treat rare and complex central nervous system disorders. NLS Pharmaceutics AG was founded in 2015 and is based in Stans, Switzerland. Nls Pharmaceutics is traded on NASDAQ Exchange in the United States.
NLS Pharmaceutics Stock Technical Analysis
NLS Pharmaceutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Positions Ratings Now
Positions RatingsDetermine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
NLS Pharmaceutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for NLS Pharmaceutics' price direction in advance. Along with the technical and fundamental analysis of NLS Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of NLS to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1111 | |||
| Jensen Alpha | 4.52 | |||
| Total Risk Alpha | (0.51) | |||
| Sortino Ratio | 0.203 | |||
| Treynor Ratio | (1.68) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for NLS Stock Analysis
When running NLS Pharmaceutics' price analysis, check to measure NLS Pharmaceutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NLS Pharmaceutics is operating at the current time. Most of NLS Pharmaceutics' value examination focuses on studying past and present price action to predict the probability of NLS Pharmaceutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NLS Pharmaceutics' price. Additionally, you may evaluate how the addition of NLS Pharmaceutics to your portfolios can decrease your overall portfolio volatility.